SCHEMBL1003141

SCHEMBL1003141

CCCCN(C)C(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
HPGD P15428 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CRHR1 P34998 4/20 0.43
ALDH1A1 P00352 2/20 0.42
THRB P10828 3/20 0.40
TSHR P16473 2/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
THRA P10827 1/20 0.40
HDAC6 Q9UBN7 2/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1002896 0.89 CRHR1 (0.48) HPGDLMNASMN1; SMN2MEN1KMT2A
SCHEMBL3802764 0.77 ALDH1A1 (0.47) HPGDMEN1KMT2AALDH1A1TSHR
SCHEMBL3469796 0.76 TPMT (0.48) CSNK2A2CSNK2BCSNK2A1HPGDLMNA
SCHEMBL1004408 0.74 HPGD (0.45) HPGDLMNASMN1; SMN2MEN1KMT2A
SCHEMBL14233766 0.74 ALDH1A1 (0.52) HPGDALDH1A1TSHRCYP1A2GAA
SCHEMBL1004853 0.73 HPGD (0.46) HPGDLMNASMN1; SMN2MEN1KMT2A
SCHEMBL2228900 0.72 HPGD (0.59) HPGDMEN1KMT2AALDH1A1TSHR
SCHEMBL1003369 0.72 HPGD (0.69) HPGDLMNASMN1; SMN2MEN1KMT2A
SCHEMBL10330507 0.71 KMT2A (0.59) HPGDLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL1003515 0.71 THRA (0.47) CSNK2A2CSNK2BCSNK2A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778219-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2014-07-15 US disclosed
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES UT-BATTELLE, LLC (US) 2013-12-19 US disclosed
US-8535560-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2013-09-17 US disclosed
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures UT-BATTELLE, LLC (US) 2011-01-20 US disclosed
WO-2011008664-A2 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES UT-BATTELLE, LLC (US) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES POU2F1, POU2F2, POF1B CSNK2A2 2224/4885CSNK2B 2613/4885CSNK2A1 1944/4885
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures POU2F1, POU2F2, POF1B CSNK2A2 2224/4885CSNK2B 2613/4885CSNK2A1 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.